Live Analyst Rating Changes 16810 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Steven Wheen
JARD

Steven Wheen

Jarden
Wall Street Analyst
★★★★☆
#582
on 13Foresight · ranked by our own returns
56%
Success Rate
+3.5%
Average Return
10 of 18 calls profitable · -1.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 56% of Steven Wheen's ratings turned a profit when each position was held for 1 year — averaging +3.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

37 Buy 15 Hold 4 Sell
Steven's Stock Coverage 11 ratings · 2026-08-02
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
AU:RHC
Ramsay Health Care
 Jul 29, 2026 BUY Hold
-7.1% avg upside
14 analysts
$47.60
7.33% Upside
 +0.0% ·
AU:TLX
Telix Pharmaceuticals
 Jul 22, 2026 BUY Strong Buy
+79.3% avg upside
13 analysts
$21.10
48.40% Upside
 -7.2% ·
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
 Jul 08, 2026 BUY Strong Buy
+36.4% avg upside
11 analysts
$40.20
34.88% Upside
 -0.2% ·
AU:REG
Regis Healthcare Ltd.
 Jun 18, 2026 HOLD Buy
-3.6% avg upside
6 analysts
$7.50
20.39% Upside
 +1.8% ·
AU:SHL
Sonic Healthcare Limited
 Jun 15, 2026 HOLD Buy
+17.5% avg upside
12 analysts
$22.30
1.96% Upside
 +14.4% ·
AU:HLS
Healius Limited
 May 14, 2026 SELL Strong Sell
+124.8% avg upside
10 analysts
$0.47
25.26% Upside
 -5.8% ·
AU:CSL
CSL
 May 12, 2026 HOLD Strong Buy
+54.5% avg upside
16 analysts
$191.00
55.22% Upside
 +29.5% ·
AU:COH
Cochlear
Apr 22, 2026 HOLD Hold
+47.2% avg upside
15 analysts
$169.00
40.97% Upside
 +28.6% ·
AU:IDX
Integral Diagnostics Ltd.
 Feb 25, 2026 BUY Strong Buy
+49.9% avg upside
12 analysts
$3.25
54.83% Upside
 -13.9% ·
AU:QBE
QBE Insurance Group Limited
 Feb 20, 2026 HOLD Hold
-12.9% avg upside
2 analysts
$22.00
11.08% Downside
 +18.4% ·
AU:ARX
Aroa Biosurgery Ltd
 Nov 27, 2024 HOLD Buy
+69.0% avg upside
3 analysts
$0.75
31.52% Upside
 -7.0% ·
🔒 6 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Steven Wheen — Frequently Asked Questions
How accurate are Steven Wheen's stock ratings?
Based on the calls 13Foresight could measure, about 56% of Steven's ratings were profitable over a one-year hold, with an average return of +3.5% per rating, or +59.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Steven ranked on 13Foresight?
Steven Wheen is currently ranked #582 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Steven cover?
Steven most recently has ratings on AU:RHC, AU:TLX, AU:RMD, AU:REG, AU:SHL, AU:HLS, AU:CSL, AU:COH, AU:IDX, AU:QBE, AU:ARX. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.